Apr. 23 at 5:51 PM
$SLS is about to be Re Rated . . . its decimal digit moving time.
Manipulated
$0.88B Equity is worth closer to
$8B right now - based on the Potential Value of GPS - once the P3 Results are announced - Gps will be worth every nickel of
$40B to Big Pharma.
- why can't any of the many short tools working here find 1 trial with any survival past 24 months for Control Arm Patients? ?? ??? ????
$ABBV Positive P3 Registrational Results will give Gps the FDA Green Light to treat upwards of 50,000 AML Patients Each year +100,000 Currently in remission.
xCCo estimated a Minimum of
$280K Rev Per Patient
$28B TAM Year 1 and Revenue Compounds, with infinite Dosing Regime.
$RVMD added
$15B in Market Value in a Day, Based on its Phase 3 Results ... Same thing will be happening Here.
Could Be Any Day Now.
